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In vivo and in vitro studies have demonstrated that high protein diets affect both protein synthesis 
and regulation of several cellular processes. The role of amino acids as substrate for protein synthesis 
has been established in the literature. However, the mechanism by which these amino acids modulate 
transcription and regulate the mRNA translation via mTOR-dependent signaling pathway has yet to 
be fully determined. It has been verified that mTOR is a protein responsible for activating a cascade 
of biochemical intracellular events which result in the activation of the protein translation process. Of 
the aminoacids, leucine is the most effective in stimulating protein synthesis and reducing proteolysis. 
Therefore, it promotes a positive nitrogen balance, possibly by favoring the activation of this protein. 
This amino acid also directly and indirectly stimulates the synthesis and secretion of insulin, enhancing its 
anabolic cellular effects. Therefore, this review aimed to identify the role of leucine in protein synthesis 
modulation and to discuss the metabolic aspects related to this aminoacid.
Uniterms: Leucine. Protein synthesis. Transcription Factors. mTOR. Translation Protein.
Estudos in vivo e in vitro verificaram que dietas hiperprotéicas influenciam a síntese protéica e regulam 
vários processos celulares. O papel dos aminoácidos como substrato para a síntese de proteínas já está 
bem evidenciado na literatura, porém as formas como esses aminoácidos modulam a etapa da transcrição 
e regulam a tradução do RNAm, pela via de sinalização dependente da mTOR, ainda não estão totalmente 
esclarecidas. Tem-se verificado que a mTOR é uma proteína responsável por ativar uma cascata de 
eventos bioquímicos intracelulares que culminam na ativação do processo de tradução protéica. Dentre 
todos os aminoácidos, a leucina é a mais eficaz em estimular a síntese protéica, reduzir a proteólise 
e, portanto, favorecer o balanço nitrogenado positivo, possivelmente por favorecer a ativação desta 
proteína. Além disso, este aminoácido estimula direta e indiretamente a síntese e a secreção de insulina, 
e, assim, aumenta as propriedades anabólicas celulares. Nesse sentido, a presente revisão tem como 
objetivo identificar o papel da leucina na modulação da síntese protéica e abordar aspectos metabólicos 
relacionados a este aminoácido.
Unitermos: Leucina. Síntese protéica. Fator de transcrição. mTOR. Tradução de proteínas.
INTRODUCTION
Protein synthesis in tissue is rapidly stimulated after 
nutrient consumption. Insulin and aminoacids stimulate 
protein anabolism, acting in a posterior step of gene 
transcription, i.e., on protein translation. However, the 
mechanism by which the aminoacids stimulate protein 
translation has yet to be fully determined (Proud, 2002).
Some studies have verified that high-protein diets 
stimulate protein synthesis. Some of the benefits promoted 
by this diet on body composition can be attributed to high 
consumption of branched-chain aminoacids (BCAA), 
which include the aminoacids leucine, valine and iso-
leucine (Donato et al., 2004; Layman, Walker, 2006; 
Katsanos et al., 2006). According to this hypothesis, high 
protein consumption not only increases the availability 
of substrates (aminoacids) for protein synthesis, but also 
stimulates anabolic processes observed after high protein 
consumption (Campos et al., 1999). 
Leucine has been shown to modulate the rate of 
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protein synthesis, particularly by stimulating the activity 
of proteins involved in the translation process, which is cri-
tical for cells to control protein synthesis (Anthony et al., 
2001; Lynch, Hutson, Patson, 2002a; Crozier et al., 2005; 
Garlick, 2005; Kimball, Jefferson, 2006). This modulation 
may involve the activation of specific intracellular pa-
thways involved in protein synthesis, including activation 
of the mammalian target of rapamycin (mTOR) pathway.
It has been observed that mTor responds immediate-
ly to any modification in aminoacid or energy consumption 
(Bruhat et al., 2002; Asnaghi et al., 2004). When ami-
noacid storage, particularly leucine, is elevated, mTOR 
interacts with other proteins to form protein complexes 
in order to phosphorylate their key-components, which 
are in turn responsible for translating mRNA into pro-
teins. These complexes include the binding of eukaryotic 
initiation factor 4E to the cap region; the activation via 
phosphorylation of 70 kDa-ribossomal protein S6 kina-
se-1 (S6K1); and the elongation of eIF2 factor (Fingar, 
Blenis, 2004; Hay, 2004). On the other hand, depletion 
of intracellular aminoacid pool, or their removal from the 
extracellular media, inhibits mTOR resulting in the sup-
pression of protein synthesis (Maloney, 2005). However, 
how leucine modulates these molecular events has not 
been fully elucidated.
Considering these aspects, this literature review 
aimed to identify the role of leucine in protein synthesis 
modulation and to discuss the metabolic aspects related 
to this aminoacid.
LEUCINE METABOLISM
Unlike other aminoacids that are degraded in the 
liver, BCAA (leucine, isoleucine and valine) as well as 
alanine, glutamate and aspartate are oxidized in skeletal 
muscle (Rossi, 2005). Of the 3 BCAAs, leucine pres-
ents a remarkable and higher oxidation rate compared 
to isoleucine and valine. Enzymes involved in leucine 
catabolism include mitochondrial and cytosolic branched-
chain aminoacid aminotransferases (BCAT) and the en-
zymatic complex branched-chain ketoacid dehydrogenase 
(BCKDH) (Shimomura et al., 2004). From the reaction 
catalyzed by BCAT, which is reversible, the aminoacid 
is transamined and converted into its respective ketoacid, 
α-keto-iso-caproate (KIC). Simultaneous to this reaction, 
the conversion of α-ketoglutarate – a nitrogen acceptor 
derived from BCAA – into glutamate also takes place. This 
reaction is able to promote synthesis of other aminoacids, 
such as alanine and glutamine. After the reaction catalyzed 
by BCAT, the ketoacid suffers oxidative decarboxylation, 
which is an irreversible reaction mediated by BCKDH. 
This enzymatic complex is found on the inner surface of 
the mitochondrial membrane. From this reaction, KIC is 
converted into isovaleryl-CoA which is oxidized by two 
different dehydrogenases, generating acetyl-CoA and 
acetoacetate as final products (Anthony et al., 2001).
In mammals, the BCKDH complex presents three 
enzymes: α-ketoacid decarboxylase (E1), constituted 
by the subunits 2α and 2β, dihydrolipoyl transacetylase 
(E2), and dihydrolipoyl dehydrogenase (E3) (Harris et al., 
1986). In tissues, the activity of this complex is regulated 
by a cycle of phosphorylation and dephosphorylation 
catalyzed by a specific kinase and a phosphatase. The 
phosphorylation state is primarily controlled by the activ-
ity of BCKDH kinase (BCKDHK). This enzyme promotes 
the inactivation of BCKDH, through phosphorylation of 
unit E1α. The activation of the BCKDH complex can be 
swiftly achieved by inhibition of BCKDHK promoted by 
leucine’s ketoacid and its structural analogues, including 
octanoate, α-cloroisocaproate and clorofibric acid. The 
dephosphorylation process is mediated by BCKDH phos-
phatase (BCKDHP) which is responsible for activating 
the BCKDH complex and dephosphorylating the sub-unit 
E1α (Anthony et al., 2001; Shimomura, Harris, 2006). 
The activity of this complex is influenced by hormones, 
diabetes, exercise, fasting, acidosis or protein-restricted 
diets, depending on the tissue (Araujo et al., 2006).
THE LEUCINE PARADOX
Unbalanced diets containing high leucine concen-
trations usually result in a reduction in body valine and 
isoleucine levels. This phenomenon is known as the “leu-
cine paradox”. This fact may be partly explained by the 
activation of BCAA oxidation, via complex BCKDH, le-
ading to negative BCKDHK regulation, concomitant to an 
inhibitory effect of KIC on this enzyme. These two factors 
promote BCKDH activation, depleting the ketoacids from 
other aminoacids, most notably valine and isoleucine. On 
the other hand, it should be noted that leucine administra-
tion also stimulates protein synthesis and inhibits protein 
degradation. Both situations indirectly affect the levels of 
valine and isoleucine (Shimomura, Harris, 2006).
THE INFLUENCE OF LEUCINE ON THE PRO-
TEIN SYNTHESIS MECHANISM
The anabolic effect of leucine on protein synthesis is 
of great nutritional interest for attenuation of loss of lean 
body mass, which occurs in catabolic states and in specific 
physiological conditions such as aging (Stipanuk, 2007). 
Many studies have been conducted to clarify this effect, 
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as it was previously observed that leucine, besides serving 
as a direct substrate for protein synthesis, also contributes 
toward stimulating this process, exerting a positive effect 
on the phosphorylating proteins involved in the translation 
initiation process of mRNA (Rogero, Tirapegui, 2008). 
Leucine exerts an effect on the short-term regulation 
at the level of translation in protein synthesis. This effect 
is synergistic with insulin, which is an anabolic hormone 
with a critical role of maintaining muscle protein syn-
thesis. However, insulin alone is not able to completely 
restore the rate of protein synthesis in muscle during the 
post-absorptive state, requiring protein or aminoacid 
consumption to fully restore the anabolic effect (Rogero, 
Tirapegui, 2008; Bolster, Kimbal, Jefferson, 2003).
Leucine also plays a role as an insulin secretagogue. 
Oral leucine administration results in a slight transient 
increase in serum insulin levels, which also stimulates 
protein synthesis induced by this aminoacid (Rogero, Ti-
rapegui, 2008; Bolster, Kimbal, Jefferson, 2003). Although 
basal insulin levels are important to potentialize the effect 
mediated by leucine (Stipanuk, 2007), this aminoacid also 
acts as a nutrient signal which regulates protein synthesis 
in adipocytes, as well as in other cells, through an insulin-
independent mechanisms (Lynch et al., 2002). This result 
may be a consequence of a direct (leucine action) or in-
direct (leucine metabolite, such as KIC) effect on tissue, 
as this effect has been already observed in isolated cells. 
Additionally, these effects were also seen in in vitro and in 
vivo studies with infusion of norleucine, an analogue com-
pound of leucine that does not stimulate insulin secretion 
nor is incorporated into the protein structure (Anthony et 
al., 2001; Lynch et al., 2000, 2002b). 
There are specific pathways favoring protein syn-
thesis, as well as cell growth and proliferation, such as 
the pathway mediated by mTOR protein. This pathway 
is stimulated by mitogens, including insulin and BCAA 
but particularly leucine (Cota et al., 2006). However, the 
mechanism underlying this effect has yet to be elucidated. 
The insulin signaling pathway initiates with insulin 
binding to its receptor. Once activated, the insulin recep-
tor phosphorylates many protein substrates for tyrosine. 
Some of these substrates belong to the insulin receptor 
substrate family, the IRS proteins (Zick, 2004; Gual, Le 
Marchnd-Brsutel, Tanti, 2005). Phosphorylation of IRS 
proteins for tyrosine creates recognition sites for a number 
of molecules such as the enzyme phosphatidylinosytol-3-
kinase (PI 3-K). There is a close association between this 
enzyme and insulin receptor substrate-1 (IRS-1) (Kim et 
al., 1999). The protein target of this enzyme is Akt/PKB, 
which is responsible for regulating glucose transport. In 
peripheral tissues, the phosphorylation of Akt/PKB pro-
motes a number of effects such as translocation of glucose 
transporter type 4 (GLUT-4) to plasma membrane, regu-
lation of protein synthesis, glycogen metabolism and cell 
cycle progression (Georgakis, Younes, 2006).
Leucine also stimulates protein synthesis by modu-
lating elements that are involved in the insulin signaling 
pathway translation via PI3-K (Figure 2). Therefore, this 
aminoacid inhibits insulin signaling (Krebs et al., 2002), 
possibly activating mTOR, which stimulates IRS-1 phos-
phorylation, and consequently reduces PI3-K activity 
(Kimball et al., 1999).
Moreover, this protein also reduces the inhibitory 
action of the tuberous sclerosis complex (TSC1/TSC2). 
The inhibition of this complex allows the activation of 
protein kinase Ras homologue-enriched in brain (Rheb), 
leading to mTor phosphorylation and activation and 
consequently to phosphorylation and activation of S6K1 
protein. The activation of this protein phosphorylates and 
activates ribossomal protein S6, favoring the synthesis of 
RNA, ribossomal proteins and elongation factors (Yang, 
Guan, 2007).
Leucine also exerts effects on the regulation of S6K1 
protein, eukaryotic initiation factors (eIFs) and eukaryotic 
initiation factor 4E binding protein 1 (4E-BP1), which are 
involved in the initiation phase of protein synthesis, i.e. in 
protein translation (Kimball et al., 1999).
Leucine stimulates mTOR activity by phosphoryla-
ting and inhibiting 4E-BP1. Dissociation of 4E-BP1 com-
plex promotes the formation of eukaryotic initiation factor 
FIGURE 1 – Leucine metabolism. Adapted from Smith, Marks 
and Liberman (2005).
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4E (eIF4E), which is crucial to initiate the translation 
process. Moreover, leucine stimulates a second initiation 
factor-4G (eIF4G) through the mTor-independent pa-
thway. The association of these two factors, eIF4E and eI-
F4G, forms a ribossomal complex eIF4F, which regulates 
translation initiation (Donato et al., 2007; Stipanuk, 2007).
Therefore, leucine also stimulates the synthesis of 
complexes that are responsible for protein translation pro-
cess and consequently enhances cellular ability for protein 
synthesis (Kimball et al., 1999; Donato et al., 2007).
EXPERIMENTAL STUDIES
The molecular mechanisms involved in stimulating 
protein synthesis by leucine were evaluated in human stu-
dies. Studies evidenced that intravenous leucine infusion at 
high doses (3 to 7 g) resulted in anabolic changes in protein 
turnover and nitrogen balance (Platell et al., 2000; Mat-
thews, 2005). Additionally, it was observed that leucine 
stimulates protein synthesis during catabolic conditions 
induced by acute food restriction or by exhaustive exercise 
(Donato et al., 2007; Biolo et al., 1997).
It was also evidenced that, after overnight fasting or 
intense exercise, protein synthesis was reduced compared 
to the rate of protein degradation in muscle. This catabolic 
period persisted until adequate amounts of protein, spe-
cifically leucine, are consumed in order to increase the 
plasma and intracellular concentrations of this aminoacid 
(Phillips, 2004). Layman and Walker (2006) emphasized 
that the regulatory role of leucine is more important du-
ring catabolic periods such as fasting or low-calorie diets 
aiming to promote body weight loss, when plasma and 
intracellular concentrations of this aminoacid are low.
Although the effect of acute leucine supplementation 
in stimulating the anabolic process of protein synthesis 
has been verified, few studies have evaluated the effi-
ciency of long-term leucine supplementation. Lynch et al. 
(2001) verified the effect of 12-day leucine or norleucine 
supplementation, on protein synthesis in rats. These au-
thors observed that leucine and norleucine increased the 
rate of protein synthesis in adipose tissue, gastrocnemius 
muscle and in the liver, suggesting that leucine is able to 
stimulate protein synthesis through insulin-independent 
mechanisms.
In a study conducted by Donato et al. (2006), the 
effect of chronic leucine supplementation on body com-
position and indicators of protein nutritional status was 
evaluated in Wistar rats submitted to 50% food restriction 
for six weeks. In this experiment, maintenance of lean 
body mass and body protein content in the supplemented 
animals was not confirmed. However, lower body fat 
compared to non-supplemented animals was observed. 
This study also showed higher concentration of hepatic 
protein and RNA in the gastrocnemius muscle of the 
supplemented group. These results indicated that leucine 
supplementation in rats submitted to food restriction sti-
mulated body fat loss, improved hepatic protein status and 
protein synthesis ability in muscle.
The authors did not consider the findings related to 
body composition striking, considering that some human 
studies have already evidenced that an increase in BCAA 
consumption can improve the body loss process (Lay-
man et al., 2003a., Mourier et al., 1997; Layman, 2003; 
Layman et al., 2003b). Furthermore, studies comparing 
diets with different protein concentrations demonstrated 
significant changes in body composition in groups on a 
high-protein diet, especially by reducing fat mass and 
lowering loss of lean body mass. These changes were 
partially attributed to increased BCAA consumption, 
particularly leucine (Layman et al., 2003b; Farnsworth et 
al., 2003; Westerterp-Plantenga et al., 2004).
A study using Wistar rats submitted to 3 cycles of 
food restriction and refeeding (1 week of 50% food restric-
tion, followed by 2-weeks on ad libitum diet, per cycle), 
with or without chronic L-leucine plus L-phenylalanine 
supplementation, demonstrated a significant increase in 
FIGURE 2 – Regulation of mTOR pathway by insulin and 
leucine. Adapted from Hinault et al. (2006).
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lean body mass and body protein content in the supple-
mented group compared to the rats submitted to the same 
protocol without supplementation (Donato et al., 2007). 
 In a study aiming to investigate the possible me-
chanisms by which leucine stimulates protein synthesis, 
Anthony et al. (2000) evaluated protein synthesis in the 
skeletal muscle of animals submitted to food restriction 
for 18 hours, and in animals with free access to food. Su-
pplementation with leucine, carbohydrate or leucine plus 
carbohydrate was orally administered to these groups. 
The authors verified that protein synthesis was restored 
similarly in both groups with leucine supplementation 
or without restriction. This effect was due to 4E-BP1 
phosphorylation and formation of complex eIF4E-eIF4G. 
The results suggested that leucine had stimulated protein 
synthesis in the skeletal muscle possibly by activating the 
mTor signaling pathway, which promoted an increase in 
eIF4F formation.
O’Connor et al. (2003) observed that aminoacid 
infusion was able to increase protein synthesis in the ske-
letal muscle of neonate pigs. This effect was mediated by 
translation eIF activation. Escobar et al. (2006) reported 
that a physiological increase in plasma leucine levels, but 
not in isoleucine and valine, allowed this aminoacid to 
act as a nutrient signal to stimulate protein synthesis in 
skeletal and cardiac muscle of neonate pigs, increasing 
the availability of translation eIF, more specifically eIF4E, 
which is necessary to form the eIF4F complex.
Recently, Ventrucci, Mello and Gomes-Marcondes 
(2007) verified that leucine supplementation in pregnant 
rats with cancer prevented reduction in plasma insulin 
levels and increased protein kinase S6K1 and translation 
eIF expression. Based on these results, the authors sug-
gested that a high-leucine diet increases protein synthesis 
in skeletal muscle of pregnant rats with tumor, possibly 
by activating eIF factors and/or the S6K1 pathway, thus 
emphasizing the role of leucine in the protein translation 
process.
FINAL CONSIDERATIONS
In summary, this review demonstrated that leucine 
regulates gene expression through multiple mechanisms 
including modulation of mTor activation, formation of the 
eIF4F complex, and phosphorylation of S6K1, consequen-
tly favoring protein synthesis.
Moreover, some studies have indicated that the 
anabolic effect of leucine is more evident in catabolic 
situations when leucine plasma and intracellular concen-
trations are low.
Leucine also exerts a notable effect on protein tur-
nover and is able to promote catabolism of aminoacids, 
such as valine and isoleucine. This effect involves indirect 
downregulation of an enzyme responsible for their catabo-
lism, resulting in reduced body aminoacids levels.
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